Is the Easier Way Ever the Better Way?

被引：60
作者：
Chi, Dennis S. [1 ]
Bristow, Robert E. [2 ]
Armstrong, Deborah K. [3 ]
Karlan, Beth Y. [4 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Univ Calif Irvine, Irvine Med Ctr, Irvine, CA USA
[3] Johns Hopkins Kimmel Canc Ctr, Baltimore, MD USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 31期
关键词：
ADVANCED OVARIAN-CANCER; GYNECOLOGIC-ONCOLOGY-GROUP; PRIMARY PERITONEAL CANCER; IIIC EPITHELIAL OVARIAN; NEOADJUVANT CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; IMPROVED SURVIVAL; SURGICAL EFFORT; INTERVAL; METAANALYSIS;
D O I：
10.1200/JCO.2011.35.9935
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4073 / 4075
页数：3
相关论文
共 18 条
  • [1] Aggressive surgical effort and improved survival in advanced-stage ovarian cancer
    Aletti, GD
    Dowdy, SC
    Gostout, BS
    Jones, MB
    Stanhope, CR
    Wilson, TO
    Podratz, KC
    Cliby, WA
    [J]. OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) : 77 - 85
  • [2] Intraperitoneal cisplatin and paclitaxel in ovarian cancer
    Armstrong, DK
    Bundy, B
    Wenzel, L
    Huang, HQ
    Baergen, R
    Lele, S
    Copeland, LJ
    Walker, JL
    Burger, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) : 34 - 43
  • [3] Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
    Bristow, RE
    Tomacruz, RS
    Armstrong, DK
    Trimble, EL
    Montz, FJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) : 1248 - 1259
  • [4] Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction
    Bristow, Robert E.
    Eisenhauer, Eric L.
    Santillan, Antonio
    Chi, Dennis S.
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 104 (02) : 480 - 490
  • [5] Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: A meta-analysis
    Bristow, Robert E.
    Chi, Dennis S.
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 103 (03) : 1070 - 1076
  • [6] Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: A Gynecologic oncology group study
    Burger, Robert A.
    Sill, Michael W.
    Monk, Bradley J.
    Greer, Benjamin E.
    Sorosky, Joel I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (33) : 5165 - 5171
  • [7] What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
    Chi, D. S.
    Eisenhauer, E. L.
    Lang, J.
    Huh, J.
    Haddad, L.
    Abu-Rustum, N. R.
    Sonoda, Y.
    Levine, D. A.
    Hensley, M.
    Barakat, R. R.
    [J]. GYNECOLOGIC ONCOLOGY, 2006, 103 (02) : 559 - 564
  • [8] The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas
    Chi, Dennis S.
    Zivanovic, Oliver
    Levinson, Kimberly L.
    Kolev, Valentin
    Huh, Jae
    Dottino, Joseph
    Gardner, Ginger J.
    Leitao, Mario M., Jr.
    Levine, Douglas A.
    Sonoda, Yukio
    Abu-Rustum, Nadeem R.
    Brown, Carol L.
    Barakat, Richard R.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 119 (01) : 38 - 42
  • [9] Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
    Chi, Dennis S.
    Eisenhauer, Eric L.
    Zivanovic, Oliver
    Sonoda, Yukio
    Abu-Rustum, Nadeem R.
    Levine, Douglas A.
    Guile, Matthew W.
    Bristow, Robert E.
    Aghajanian, Carol
    Barakat, Richard R.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 114 (01) : 26 - 31
  • [10] Does aggressive surgery only benefit patients with less advanced ovarian cancer? Results from an international comparison within the SCOTROC-1 Trial
    Crawford, SC
    Vasey, PA
    Paul, J
    Hay, A
    Davis, JA
    Kaye, SB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) : 8802 - 8811
12